1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Hypertension Partnering 2010-2015

Hypertension Partnering 2010-2015

  • March 2015
  • -
  • Currentpartnering
  • -
  • 100 pages

The Hypertension Partnering 2010-2015 report provides understanding and access to the hypertension partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in hypertension partnering deals
Top hypertension deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

The Hypertension Partnering 2010-2015 provides understanding and access to the hypertension partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of hypertension partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors hypertension technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 60 links to online copies of actual hypertension deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of hypertension partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 3 provides an overview of the average deal terms since 2010. The chapter includes deals with a stage of development announced by headline value, upfront value, milestone value and royalty rate. Numerous tables outline financial trends.

Chapter 4 provides an overview of the most active dealmakers, top dealmakers by value, active big pharma and big biotech dealmakers including contract documents where available.

Chapter 5 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of hypertension technologies and products.

Report scope

Hypertension Partnering 2010-2015 is intended to provide the reader with an in-depth understanding and access to hypertension trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

Trends in hypertension dealmaking in the biopharma industry since 2010
Access to summary headline, upfront, milestone and royalty data
Access to over 60 hypertension deals and contract documents where available
The leading hypertension deals by value since 2010

In Hypertension Partnering 2010-2015, the available deals are listed by:

Headline value
Upfront payment value
Royalty rate value
Company A-Z
Industry sector
Stage of development at signing
Deal component type
Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Table Of Contents

Hypertension Partnering 2010-2015
Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in hypertension partnering

2.1. Introduction
2.2. Hypertension partnering over the years
2.3. Hypertension partnering by deal type
2.4. Hypertension partnering industry sector
2.5. Hypertension partnering by stage of development
2.6. Hypertension partnering by technology type

Chapter 3 - Average deal terms for hypertension

3.1 Introduction
3.2 Average deal terms for hypertension
3.3 Hypertension headline values with median calculation
3.4 Hypertension upfront values with median calculation
3.5 Hypertension milestone values with median calculation
3.6 Hypertension royalty rates with median calculation

Chapter 4 - Active hypertension dealmakers

4.1. Introduction
4.2 Most active hypertension dealmakers
4.3. Top hypertension deals by value
4.4 Big pharma deal activity
4.5 Big biotech deal activity

Chapter 5 - Hypertension dealmaking directory

5.1. Introduction
5.2. Company A-Z
5.3. By deal type
5.4. By industry sector
5.5. By stage of development
5.6. By technology type

Chapter 6 - Partnering resource center

6.1. Online partnering
6.2. Partnering events
6.3. Further reading on dealmaking

Appendices

Appendix 1 - Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering
Order Form - Reports
Order Form - Subscription Access Products

Table of figures

Figure 1: Hypertension partnering since 2010
Figure 2: Hypertension dealmaking activity- 2010 to 2015
Figure 3: Hypertension partnering by deal type since 2010
Figure 4: Hypertension partnering by industry sector since 2010
Figure 5: Hypertension partnering by stage of development since 2010
Figure 6: Hypertension partnering by technology type since 2010
Figure 7: Hypertension deals with a headline value
Figure 8: Hypertension deals with upfront payment values
Figure 9: Hypertension deals with milestone payments
Figure 10: Hypertension deals with royalty rates, %
Figure 11: Top hypertension deals by value since 2010
Figure 12: Big pharma - top 50 - hypertension deals 2010 to 2015
Figure 13: Big pharma hypertension deal frequency - 2010 to 2015
Figure 14: Big biotech - top 50 - hypertension deals 2010 to 2015
Figure 15: Big biotech hypertension deal frequency - 2010 to 2015
Figure 16: Online partnering resources
Figure 17: Forthcoming partnering events
Figure 18: Deal type definitions

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Hypertension Forecast in 12 Major Markets 2016-2026

Epiomic Epidemiology Series: Hypertension Forecast in 12 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • November 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Hypertension in 12 Major Markets Hypertension (high blood pressure) is a common condition in which the force of the blood against the ...

Pulmonary Arterial Hypertension (PAH) - Market Insights, Epidemiology and Market Forecast-2023

Pulmonary Arterial Hypertension (PAH) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Pulmonary Arterial Hypertension (PAH) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Pulmonary ...

Global Hypertension Management Devices Market Research Report 2016

Global Hypertension Management Devices Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Hypertension Management Devices Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Hypertension Management Devices industry, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.